Navigating complex, global ancillary supply demands
Ancillary supplies are essential to protocol execution - but inconsistent supply, limited site readiness, and/or regulatory missteps can compromise timelines. As clinical trials protocols grow more specialized and geographically dispersed, biotech and biopharma companies are re-evaluating how they manage ancillary sourcing, oversight, and delivery.
In this session, Thermo Fisher's clinical ancillary management (CAM) subject matter expert will share how their services support patient-first readiness, reduce supply-related delays, and adapt to the evolving needs of global studies.
Attendees will learn:
- How early planning and flexible supply models help ensure site readiness
- Why centralized CAM oversight supports risk mitigation across regions
- What tiered services can offer trials with varying scope or complexity
- How regulatory alignment and supplier performance affect delivery reliability
Meet the Speaker
Molly Isermann
Senior Manager Product Management, Clinical Ancillary Management – Pharma Services Group
Join us for new insights. Register now to attend!
By completing this form you agree Citeline and Thermo Fisher Scientific Inc. may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and Thermo Fisher Scientific Inc
Inspire. Connect. Innovate.
